The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis

Biochemical and Biophysical Research Communications

Volumn 380, Issue 3, 2009, Pages 684-688

  Ando, Hitoshi ^a,b   Takamura, Toshinari ^a   Matsuzawa Nagata, Naoto ^a   Shima, Kosuke R ^a   Nakamura, Seiji ^a   Kumazaki, Masafumi ^a   Kurita, Seiichiro ^a   Misu, Hirofumi ^a   Togawa, Naoyuki ^c   Fukushima, Tatsunobu ^c   Fujimura, Akio ^b   Kaneko, Shuichi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b School of Medicine   (Japan)

^c MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

Atherogenic diet; Circadian rhythm; Clock gene; Non alcoholic steatohepatitis; Oxidative stress

Indexed keywords

LIPID; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; CARBOHYDRATE METABOLISM; CIRCADIAN RHYTHM; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL CLOCKS; CIRCADIAN RHYTHM; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; FATTY LIVER; GENE EXPRESSION PROFILING; LIVER; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

MUS;

EID: 60549117283     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.01.150     Document Type: Article

References (36)

1. Lowrey P.L., and Takahashi J.S. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu. Rev. Genomics Hum. Genet. 5 (2004) 407-441
2. Reppert S.M., and Weaver D.R. Coordination of circadian timing in mammals. Nature 418 (2002) 935-941
3. Yoo S.H., Yamazaki S., Lowrey P.L., Shimomura K., Ko C.H., Buhr E.D., Siepka S.M., Hong H.K., Oh W.J., Yoo O.J., Menaker M., and Takahashi J.S. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc. Natl. Acad. Sci. USA 101 (2004) 5339-5346
4. Yang X., Downes M., Yu R.T., Bookout A.L., He W., Straume M., Mangelsdorf D.J., and Evans R.M. Nuclear receptor expression links the circadian clock to metabolism. Cell 126 (2006) 801-810
5. Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., Laposky A., Losee-Olson S., Easton A., Jensen D.R., Eckel R.H., Takahashi J.S., and Bass J. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308 (2005) 1043-1045
6. Ando H., Yanagihara H., Hayashi Y., Obi Y., Tsuruoka S., Takamura T., Kaneko S., and Fujimura A. Rhythmic messenger ribonucleic acid expression of clock genes and adipocytokines in mouse visceral adipose tissue. Endocrinology 146 (2005) 5631-5636
7. Ando H., Takamura T., Matsuzawa-Nagata N., Shima K.R., Eto T., Misu H., Shiramoto M., Tsuru T., Irie S., Fujimura A., and Kaneko S. Clock gene expression in peripheral leucocytes of patients with type 2 diabetes. Diabetologia 52 (2009) 329-335
8. Woon P.Y., Kaisaki P.J., Braganca J., Bihoreau M.T., Levy J.C., Farrall M., and Gauguier D. Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc. Natl. Acad. Sci. USA 104 (2007) 14412-14417
9. Scott E.M., Carter A.M., and Grant P.J. Association between polymorphisms in the Clock geneobesity and the metabolic syndrome in man. Int. J. Obes. (Lond.) 32 (2008) 658-662
10. Sookoian S., Castano G., Gemma C., Gianotti T.F., and Pirola C.J. Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease. World J. Gastroenterol. 13 (2007) 4242-4248
11. Hirota T., Okano T., Kokame K., Shirotani-Ikejima H., Miyata T., and Fukada Y. Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts. J. Biol. Chem. 277 (2002) 44244-44251
12. Rutter J., Reick M., Wu L.C., and McKnight S.L. Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science 293 (2001) 510-514
13. Kohsaka A., Laposky A.D., Ramsey K.M., Estrada C., Joshu C., Kobayashi Y., Turek F.W., and Bass J. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab. 6 (2007) 414-421
14. Oishi K., Kasamatsu M., and Ishida N. Gene- and tissue-specific alterations of circadian clock gene expression in streptozotocin-induced diabetic mice under restricted feeding. Biochem. Biophys. Res. Commun. 317 (2004) 330-334
15. H. Ando, K. Ushijima, H. Yanagihara, Y. Hayashi, T. Takamura, S. Kaneko, A. Fujimura, Clock gene expression in the liver and adipose tissues of non-obese type 2 diabetic Goto-Kakizaki rats, Clin. Exp. Hypertens., in press.
16. Yanagihara H., Ando H., Hayashi Y., Obi Y., and Fujimura A. High-fat feeding exerts minimal effects on rhythmic mRNA expression of clock genes in mouse peripheral tissues. Chronobiol. Int. 23 (2006) 905-914
17. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99-S112
18. Matsuzawa N., Takamura T., Kurita S., Misu H., Ota T., Ando H., Yokoyama M., Honda M., Zen Y., Nakanuma Y., Miyamoto K., and Kaneko S. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46 (2007) 1392-1403
19. Takamura T., Sakurai M., Ota T., Ando H., Honda M., and Kaneko S. Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients. Diabetologia 47 (2004) 638-647
20. Takeshita Y., Takamura T., Hamaguchi E., Shimizu A., Ota T., Sakurai M., and Kaneko S. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line. Metabolism 55 (2006) 1464-1472
21. Misu H., Takamura T., Matsuzawa N., Shimizu A., Ota T., Sakurai M., Ando H., Arai K., Yamashita T., Honda M., Yamashita T., and Kaneko S. Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes. Diabetologia 50 (2007) 268-277
22. Takeshita Y., Takamura T., Ando H., Hamaguchi E., Takazakura A., Matsuzawa-Nagata N., and Kaneko S. Cross talk of tumor necrosis factor-alpha and the renin-angiotensin system in tumor necrosis factor-alpha-induced plasminogen activator inhibitor-1 production from hepatocytes. Eur. J. Pharmacol. 579 (2008) 426-432
23. T. Takamura, H. Misu, N. Matsuzawa-Nagata, M. Sakurai, T. Ota, A. Shimizu, S. Kurita, Y. Takeshita, H. Ando, M. Honda, S. Kaneko, Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients, Obesity, in press (Epub ahead of print).
24. Takamura T., Misu H., Yamashita T., and Kaneko S. SAGE application in the study of diabetes. Curr. Pharm. Biotechnol. 9 (2008) 392-399
25. Shimizu A., Takamura T., Matsuzawa N., Nakamura S., Nabemoto S., Takeshita Y., Misu H., Kurita S., Sakurai M., Yokoyama M., Zen Y., Sasaki M., Nakanuma Y., and Kaneko S. Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line. Metabolism 56 (2007) 1478-1485
26. Ando H., Oshima Y., Yanagihara H., Hayashi Y., Takamura T., Kaneko S., and Fujimura A. Profile of rhythmic gene expression in the livers of obese diabetic KK-A(y) mice. Biochem. Biophys. Res. Commun. 346 (2006) 1297-1302
27. Matsuzawa-Nagata N., Takamura T., Ando H., Nakamura S., Kurita S., Misu H., Ota T., Yokoyama M., Honda M., Miyamoto K., and Kaneko S. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 57 (2008) 1071-1077
28. Uno M., Kurita S., Misu H., Ando H., Ota T., Matsuzawa-Nagata N., Kita Y., Nabemoto S., Akahori H., Zen Y., Nakanuma Y., Kaneko S., and Takamura T. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. Hepatology 48 (2008) 109-118
29. Kurita S., Takamura T., Ota T., Matsuzawa-Nagata N., Kita Y., Uno M., Nabemoto S., Ishikura K., Misu H., Ando H., Zen Y., Nakanuma Y., and Kaneko S. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects. Eur. J. Pharmacol. 588 (2008) 316-324
30. Hardeland R., Coto-Montes A., and Poeggeler B. Circadian rhythms, oxidative stress, and antioxidative defense mechanisms. Chronobiol. Int. 20 (2003) 921-962
31. Langmesser S., and Albrecht U. Life time-circadian clocks, mitochondria and metabolism. Chronobiol. Int. 23 (2006) 151-157
32. Obrietan K., Impey S., and Storm D.R. Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei. Nat. Neurosci. 1 (1998) 693-700
33. Fu L., Pelicano H., Liu J., Huang P., and Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111 (2002) 41-50
34. Kudo T., Akiyama M., Kuriyama K., Sudo M., Moriya T., and Shibata S. Night-time restricted feeding normalises clock genes and Pai-1 gene expression in the db/db mouse liver. Diabetologia 47 (2004) 1425-1436
35. Busino L., Bassermann F., Maiolica A., Lee C., Nolan P.M., Godinho S.I., Draetta G.F., and Pagano M. SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins. Science 316 (2007) 900-904
36. Gatfield D., and Schibler U. Physiology. Proteasomes keep the circadian clock ticking. Science 316 (2007) 1135-1136